NCT00030108 2012-03-15Ixabepilone in Treating Young Patients With Solid Tumors or Leukemia That Haven't Responded to TherapyNational Institutes of Health Clinical Center (CC)Phase 1 Completed30 enrolled
NCT01454479 2011-10-19A Phase I Study of Lapatinib (Tykerb) Plus Ixabepilone (Ixempra) as 2nd-line Treatment for Patients With HER-2 Overexpressed Recurrent or Persistent Endometrial Carcinoma or CarcinosarcomaChang Gung Memorial HospitalPhase 1 Unknown24 enrolled